title: Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 981045-2092, USA.
authors.forename: C
authors.initials: C
authors.lastname: Yu
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: I
authors.initials: I
authors.lastname: Braude
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: F G
authors.initials: FG
authors.lastname: Schuening
authors.forename: R
authors.initials: R
authors.lastname: Huss
authors.forename: T C
authors.initials: TC
authors.lastname: Graham
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology* / Q000379:methods; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage*; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D008727:Methotrexate / Q000008:administration & dosage*
chemical_list: D003346:Corticotropin-Releasing Hormone; D008727:Methotrexate